These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37935200)

  • 1. Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial.
    Cukoski S; Lindemann CH; Arjune S; Todorova P; Brecht T; Kühn A; Oehm S; Strubl S; Becker I; Kämmerer U; Torres JA; Meyer F; Schömig T; Hokamp NG; Siedek F; Gottschalk I; Benzing T; Schmidt J; Antczak P; Weimbs T; Grundmann F; Müller RU
    Cell Rep Med; 2023 Nov; 4(11):101283. PubMed ID: 37935200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
    Oehm S; Steinke K; Schmidt J; Arjune S; Todorova P; Heinrich Lindemann C; Wöstmann F; Meyer F; Siedek F; Weimbs T; Müller RU; Grundmann F
    Nephrol Dial Transplant; 2023 Jun; 38(7):1623-1635. PubMed ID: 36423335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects.
    Strubl S; Oehm S; Torres JA; Grundmann F; Haratani J; Decker M; Vuong S; Kaur Bhandal A; Methot N; Haynie-Cion R; Meyer F; Siedek F; Korst U; Müller RU; Weimbs T
    Clin Kidney J; 2022 Jun; 15(6):1079-1092. PubMed ID: 35664270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence.
    Pezzuoli C; Biagini G; Magistroni R
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Kidney Disease Diet: What is Known and What is Safe.
    Chebib FT; Nowak KL; Chonchol MB; Bing K; Ghanem A; Rahbari-Oskoui FF; Dahl NK; Mrug M
    Clin J Am Soc Nephrol; 2024 May; 19(5):664-682. PubMed ID: 37729939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.
    Pickel L; Iliuta IA; Scholey J; Pei Y; Sung HK
    Adv Nutr; 2022 Mar; 13(2):652-666. PubMed ID: 34755831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
    Torres VE; Meijer E; Bae KT; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang JJ; Czerwiec FS
    Am J Kidney Dis; 2011 May; 57(5):692-9. PubMed ID: 21333426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
    van Aerts RMM; Kievit W; D'Agnolo HMA; Blijdorp CJ; Casteleijn NF; Dekker SEI; de Fijter JW; van Gastel M; Gevers TJ; van de Laarschot LFM; Lantinga MA; Losekoot M; Meijer E; Messchendorp AL; Neijenhuis MK; Pena MJ; Peters DJM; Salih M; Soonawala D; Spithoven EM; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; Drenth JPH;
    Gastroenterology; 2019 Aug; 157(2):481-491.e7. PubMed ID: 31022403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.
    Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Wetzels JF; Drenth JP
    Liver Int; 2015 May; 35(5):1607-14. PubMed ID: 25369108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease.
    Rosati E; Condello G; Tacente C; Mariani I; Tommolini V; Calvaruso L; Fulignati P; Grandaliano G; Pesce F
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.
    Meijer E; Drenth JP; d'Agnolo H; Casteleijn NF; de Fijter JW; Gevers TJ; Kappert P; Peters DJ; Salih M; Soonawala D; Spithoven EM; Torres VE; Visser FW; Wetzels JF; Zietse R; Gansevoort RT;
    Am J Kidney Dis; 2014 Mar; 63(3):446-55. PubMed ID: 24342522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
    Cadnapaphornchai MA; George DM; McFann K; Wang W; Gitomer B; Strain JD; Schrier RW
    Clin J Am Soc Nephrol; 2014 May; 9(5):889-96. PubMed ID: 24721893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease.
    Seliger SL; Abebe KZ; Hallows KR; Miskulin DC; Perrone RD; Watnick T; Bae KT
    Am J Nephrol; 2018; 47(5):352-360. PubMed ID: 29779024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.
    Schaefer F; Mekahli D; Emma F; Gilbert RD; Bockenhauer D; Cadnapaphornchai MA; Shi L; Dandurand A; Sikes K; Shoaf SE
    Eur J Pediatr; 2019 Jul; 178(7):1013-1021. PubMed ID: 31053954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
    Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK
    BMJ Open; 2018 Jan; 8(1):e018794. PubMed ID: 29358433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't.
    Ong ACM; Torra R
    Clin Kidney J; 2022 Jun; 15(6):1034-1036. PubMed ID: 35664267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
    Chapman AB
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1197-204. PubMed ID: 18579674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
    Gansevoort RT; Hariri A; Minini P; Ahn C; Chapman AB; Horie S; Knebelmann B; Mrug M; Ong ACM; Pei YPC; Torres VE; Modur V; Antonshchuk I; Perrone RD
    Am J Kidney Dis; 2023 May; 81(5):517-527.e1. PubMed ID: 36535535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.